--- title: "Prevail expects a net loss of 140 million to 215 million yuan for the year" type: "News" locale: "en" url: "https://longbridge.com/en/news/226004731.md" description: "According to the Zhitong Finance APP, Prevail disclosed its performance forecast for 2024, expecting a net loss attributable to shareholders of the listed company of between 140 million yuan and 215 million yuan; the net loss after deducting non-recurring gains and losses is expected to be between 146 million yuan and 221 million yuan" datetime: "2025-01-23T13:20:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/226004731.md) - [en](https://longbridge.com/en/news/226004731.md) - [zh-HK](https://longbridge.com/zh-HK/news/226004731.md) generator: "portal-rs" --- # Prevail expects a net loss of 140 million to 215 million yuan for the year According to the Zhitong Finance APP, Prevail (300710.SZ) disclosed its performance forecast for the year 2024, expecting a net loss attributable to shareholders of the listed company of between 140 million yuan and 215 million yuan; the net loss after deducting non-recurring gains and losses is expected to be between 146 million yuan and 221 million yuan ### Related Stocks - [300710.CN](https://longbridge.com/en/quote/300710.CN.md) ## Related News & Research - [Negative Link Announces Global Expansion and Next Phase of Growth](https://longbridge.com/en/news/296644416.md) - [Oura exploring how its ring could detect brain hemorrhages after Bill Ackman suggests it could have helped his daughter](https://longbridge.com/en/news/296658401.md) - [DQ: Sequential revenue growth and narrowed losses, with AIDC expansion and strong liquidity amid industry headwinds](https://longbridge.com/en/news/296508129.md) - [Hocklynn Releases Industry Study Highlighting Fatigue-Risk Advantages of Punching Over Laser Cutting](https://longbridge.com/en/news/296635862.md) - [23:12 ETJA Powers Fisher & Paykel Healthcare's Green Transition with New Zealand's Largest Rooftop PV System](https://longbridge.com/en/news/296428718.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**